We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 8.85 | 8.70 | 9.00 | 8.85 | 8.85 | 8.85 | 1,881,932 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0163 | -5.43 | 15.4M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 02/12/2020 12:40 | RNS Number : 2890H SkinBioTherapeutics PLC 02 December 2020 2 December 2020 SkinBioTherapeutics plc Notice of Results SkinBioTherapeutics plc's (AIM: SBTX or the "Company") financial results for the twelve months to 30 June 2020 will be released on Friday 4 December 2020. The results will be available on the Company's website following release to the London Stock Exchange. For more information please contact: | kenway | |
| 30/11/2020 08:08 | RHS formation forming on the chart at present Downside move possible from this formation is from shoulders to previous peak ie around 10p USA and the UK Market weakness on no SBTX news could therefore result in a retest of 5p imo dyor | buywell3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
